Sector : Pharmaceuticals
BSE
279.30 1.1%
NSE
279.25 1.21 %
Feb 11, 15:39
Feb 10, 16:40
Cadila Health gains 3% on Establishment Inspection Report from USFDA
Feb 10, 16:04
Cadila Healthcare gets EIR from USFDA for its Ahmedabad facility
Feb 07, 14:47
Hold Cadila Healthcare; target of Rs 247: Prabhudas Lilladher
Feb 20, 16:00
Price
BSE
279.30 1.1%
NSE
279.25 1.21%
Share Target
Target(Rs)
Tip Period
Stop Loss
Your permanent Nickname can be distinct from your username and no one need know the link between the two.
